Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

Filetype[PDF-9.47 MB]


Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
  • English
    • Details You May Also Like

    Details:

    • Corporate Authors:
      National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    • Description:
      Tuberculosis (TB) is a challenging disease to diagnose, treat, and control globally and in the United States. TB is spread through the air from one person to another. TB bacteria are released into the air when a person with TB disease of the lungs or throat coughs, sneezes, speaks, or sings. People nearby may breathe in these bacteria and become infected.

      Globally, TB is one of the most common infectious diseases and the leading cause of death among people living with HIV (PLHIV). In 2010, a total of 8.8 million people become sick with TB disease, most of whom (82%) live in one of the 22 high burden countries for TB. While significant progress has been made toward the elimination of TB in the United States, this disease remains an urgent public health problem in many other parts of the world.

      TB in the United States reflects the global reality. Latest surveillance data show the annual TB incidence rate among the U.S.-born was 1.6 per 100,000 compared to 18.1 in foreign-born individuals. In 2010, 60% of all TB cases and 88% of drug-resistant TB cases1 in the United States occurred among people born in other countries. More than 75% of these individuals were born in just 15 countries. Many of CDC’s global TB control activities are focused in these high-burden and origin countries. Investing in TB control in high-burden settings reduces TB cases in the United States, costs less than screening at U.S. entry points, and saves funds that would be spent treating TB disease in the U.S.

      CS229517-A

    • Subjects:
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov